HP is teaming up with Tecan, a global leader in laboratory automation for life sciences and diagnostics, to launch the Duo Digital Dispenser, a new solution designed to simplify how researchers isolate individual cells and develop new therapeutics.
Powered by HP’s inkjet technology, Duo combines the capabilities of the D300e Digital Dispenser and the Uno Single Cell Dispenser, delivering a major advancement in speed and precision for cancer research and other critical applications in life sciences.
By combining single-cell and reagent dispensing into one system, the new instrument significantly improves lab efficiency, reducing sample processing time, increasing reproducibility, and cutting down on labware waste and reagent use. Duo is 40 times faster than conventional methods for drug discovery, reducing dosing time from 10 minutes to 15 seconds. Cell dispensing with Duo enables researchers to isolate single cells in less than 5 minutes compared to 1 hour when using traditional cell isolation technology. The instrument features a single-use disposable component that simplifies setup, minimizes contamination risk, and enables experimental reproducibility.
In addition to dispensing cells, Duo enables researchers to dispense reagents without the use of surfactants. This innovation is especially important for scientists developing advanced biologic therapeutics, which can be particularly sensitive to surfactants.
“With the Duo Digital Dispenser, we’re delivering on the promise of HP’s inkjet and microfluidics technology to transform how life science research is done,” said Bao Nguyen, Vice President and General Manager of Specialty Printing & Technology Solutions at HP. “By simplifying complex lab workflows and increasing accessibility, we’re helping researchers spend more time on discovery and less on setup. It’s incredibly rewarding to see our technology accelerate progress in personalized medicine through our work with Tecan. We’re proud to be a partner in maximizing the potential of this revolutionary technology.”
As single-cell research and advances in therapeutic development pave the way for personalized medicine, this ongoing collaboration between HP and Tecan makes next-generation inkjet-based microfluidics accessible to a wider range of labs, including those without deep specialization. This broader adoption has the potential to significantly accelerate the development and delivery of life-changing therapeutics.
“Tecan is proud to be an industry leader in lab automation and application solutions for life sciences,” said Mukta Acharya, Executive Vice President of Tecan’s Life Sciences Division. “By combining HP’s innovative microfluidics with Tecan’s deep application expertise and global reach, we’re delivering greater precision, efficiency, and ease of use for single-cell and drug-discovery applications. We’re helping customers to scale healthcare innovation.”
HP and Tecan will continue collaborating on HP’s industry-leading microfluidics and sensing technologies to enhance the Duo Digital Dispenser and support advances in life science research.
